• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于阳性淋巴结对数优势的预后列线图预测根治性膀胱切除术后非转移性膀胱癌患者的总生存。

A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy.

机构信息

Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510289, China.

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510289, China.

出版信息

Curr Oncol. 2022 Sep 23;29(10):6834-6846. doi: 10.3390/curroncol29100539.

DOI:10.3390/curroncol29100539
PMID:36290816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9601192/
Abstract

(1) Purpose: The purpose of this study was to evaluate the prognostic capacity of the pathological N status (pN), lymph node ratio (LNR), and the log odds of positive lymph nodes (LODDS), and to build a prognostic nomogram to predict overall survival (OS) for bladder cancer patients treated by radical cystectomy. (2) Methods: The clinical and pathological characteristics of 10,938 patients with bladder cancer were identified from the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2017. The predictive capacity was assessed by univariate and multivariate Cox regression analyses, the area under the receiver operating characteristic curve (AUC), and C-index. Calibration curves, decision curve analysis (DCA), and risk-grouping were utilized to evaluate the predictive accuracy and discriminative ability of the nomogram. (3) Results: LODDS was an independent risk factor for bladder cancer (all < 0.001) and demonstrated the highest values of C-index and AUC. The values of AUCs in the training cohort were 0.747, 0.743, and 0.735 for predicting 1-, 3-, and 5-year OS, respectively. Calibration curves and DCA curves suggested the excellent clinical application value of our nomogram. (4) Conclusions: LODDS is a better predictive indicator for bladder cancer patients compared to pN and LNR. The LODDS-incorporated nomogram has excellent accuracy and promising clinical application value for non-metastatic bladder cancer after radical cystectomy.

摘要

(1)目的:本研究旨在评估病理 N 分期(pN)、淋巴结比率(LNR)和阳性淋巴结对数优势比(LODDS)的预后能力,并构建一个列线图预测接受根治性膀胱切除术治疗的膀胱癌患者的总生存(OS)。

(2)方法:从 2004 年至 2017 年,从监测、流行病学和最终结果(SEER)数据库中确定了 10938 例膀胱癌患者的临床和病理特征。通过单因素和多因素 Cox 回归分析、受试者工作特征曲线(ROC)下面积(AUC)和 C 指数评估预测能力。校准曲线、决策曲线分析(DCA)和风险分组用于评估列线图的预测准确性和判别能力。

(3)结果:LODDS 是膀胱癌的独立危险因素(均<0.001),且具有最高的 C 指数和 AUC 值。在训练队列中,预测 1、3 和 5 年 OS 的 AUC 值分别为 0.747、0.743 和 0.735。校准曲线和 DCA 曲线表明我们的列线图具有出色的临床应用价值。

(4)结论:与 pN 和 LNR 相比,LODDS 是预测膀胱癌患者的更好指标。LODDS 纳入的列线图对于接受根治性膀胱切除术的非转移性膀胱癌具有出色的准确性和有前途的临床应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/6f81cbca6f17/curroncol-29-00539-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/8be405f81a55/curroncol-29-00539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/a91a6b0be05d/curroncol-29-00539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/0a82a9c88233/curroncol-29-00539-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/57a7e549e515/curroncol-29-00539-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/7dcc7816674e/curroncol-29-00539-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/14256bc85223/curroncol-29-00539-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/6f81cbca6f17/curroncol-29-00539-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/8be405f81a55/curroncol-29-00539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/a91a6b0be05d/curroncol-29-00539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/0a82a9c88233/curroncol-29-00539-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/57a7e549e515/curroncol-29-00539-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/7dcc7816674e/curroncol-29-00539-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/14256bc85223/curroncol-29-00539-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55bf/9601192/6f81cbca6f17/curroncol-29-00539-g007.jpg

相似文献

1
A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy.基于阳性淋巴结对数优势的预后列线图预测根治性膀胱切除术后非转移性膀胱癌患者的总生存。
Curr Oncol. 2022 Sep 23;29(10):6834-6846. doi: 10.3390/curroncol29100539.
2
Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.基于淋巴结转移指标的膀胱癌患者预后列线图:一项 SEER 人群研究和外部验证。
Cancer Med. 2023 Mar;12(6):6853-6866. doi: 10.1002/cam4.5475. Epub 2022 Dec 7.
3
Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery.基于手术治疗后淋巴结阳性对数优势比预测子宫内膜癌肉瘤患者总生存期的列线图。
BMC Cancer. 2021 Oct 27;21(1):1149. doi: 10.1186/s12885-021-08888-0.
4
A Prognostic Model Based on the Log Odds Ratio of Positive Lymph Nodes Predicts Prognosis of Patients with Rectal Cancer.基于阳性淋巴结对数优势比的预后模型预测直肠癌患者的预后。
J Gastrointest Cancer. 2024 Sep;55(3):1111-1124. doi: 10.1007/s12029-024-01046-2. Epub 2024 May 3.
5
Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.结合 N 分类和基于比值的淋巴结分类的动态列线图预测肺腺癌患者手术后的长期生存:一项基于 SEER 人群的研究。
BMC Cancer. 2021 Aug 4;21(1):653. doi: 10.1186/s12885-021-08410-6.
6
Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.基于阳性淋巴结对数优势构建并验证列线图预测甲状腺髓样癌术后预后
Ann Surg Oncol. 2021 Aug;28(8):4360-4370. doi: 10.1245/s10434-020-09567-3. Epub 2021 Jan 19.
7
Log Odds of Positive Lymph Nodes (LODDS) as an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging.淋巴结阳性对数比(LODDS)作为膀胱癌根治性膀胱切除术后总生存的独立预测因素:重新考虑传统淋巴结分期的时候到了。
Clin Genitourin Cancer. 2023 Jun;21(3):e175-e181. doi: 10.1016/j.clgc.2022.12.001. Epub 2022 Dec 7.
8
Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation.淋巴结阳性对数优势在结直肠黏液腺癌预后评估中的价值:分析及外部验证。
Cancer Med. 2021 Dec;10(23):8542-8557. doi: 10.1002/cam4.4366. Epub 2021 Nov 18.
9
Establishment of a nomogram model for predicting distant metastasis in pancreatic ductal adenocarcinoma: a comparative analysis of different lymph node staging systems based on the SEER database.基于 SEER 数据库的不同淋巴结分期系统比较分析:建立预测胰腺导管腺癌远处转移的列线图模型。
Sci Rep. 2024 Aug 5;14(1):18136. doi: 10.1038/s41598-024-69126-8.
10
A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.一种基于阳性淋巴结对数优势比的预后列线图,用于预测胆管神经内分泌肿瘤(NENs)患者术后的总生存期。
J Endocrinol Invest. 2022 Dec;45(12):2341-2351. doi: 10.1007/s40618-022-01874-8. Epub 2022 Jul 30.

本文引用的文献

1
A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients With Distal Cholangiocarcinoma After Surgery.基于阳性淋巴结对数比值的列线图预测远端胆管癌患者术后预后
Front Surg. 2021 Oct 26;8:757552. doi: 10.3389/fsurg.2021.757552. eCollection 2021.
2
Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with endometrial carcinosarcoma after surgery.基于手术治疗后淋巴结阳性对数优势比预测子宫内膜癌肉瘤患者总生存期的列线图。
BMC Cancer. 2021 Oct 27;21(1):1149. doi: 10.1186/s12885-021-08888-0.
3
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).
欧洲泌尿外科学会非肌层浸润性膀胱癌(Ta、T1和原位癌)指南
Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10.
4
Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy.阳性淋巴结的对数比值是新辅助放化疗后直肠癌患者的一个优秀预后因素。
Ann Transl Med. 2021 Apr;9(8):637. doi: 10.21037/atm-20-7590.
5
Log ODDS (LODDS) of positive lymph nodes as a predictor of overall survival in squamous cell carcinoma of the penis.淋巴结阳性对数优势比(LODDS)预测阴茎鳞癌患者的总生存。
J Surg Oncol. 2021 May;123(8):1836-1844. doi: 10.1002/jso.26454. Epub 2021 Mar 8.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.基于人群的研究:开发和验证用于预测膀胱癌患者根治性膀胱切除术后癌症特异性生存的预后列线图。
Cancer Med. 2020 Dec;9(24):9303-9314. doi: 10.1002/cam4.3535. Epub 2020 Oct 16.
8
Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study.手术治疗后淋巴结阳性的肺鳞状细胞癌患者中阳性淋巴结对数比的预后价值:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Transl Lung Cancer Res. 2020 Aug;9(4):1285-1301. doi: 10.21037/tlcr-20-193.
9
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南:2020 年指南摘要。
Eur Urol. 2021 Jan;79(1):82-104. doi: 10.1016/j.eururo.2020.03.055. Epub 2020 Apr 29.
10
Nomogram for predicting overall survival of patients with bladder cancer: A population-based study.膀胱癌患者总生存预测列线图:一项基于人群的研究。
Int J Biol Markers. 2020 Jun;35(2):29-39. doi: 10.1177/1724600820907605. Epub 2020 Apr 20.